On March 8, an international scientific review board will be evaluating the research at the French CNRS Institut de Biologie Moléculaire des Plantes (IBMP) in Strasbourg. This is the place where the former star (and now misconduct-tainted pariah) of plant sciences Olivier Voinnet shot to fame, where his main lab operated since 2002 until he was taken away control over it in 2015, after found guilty of massive data manipulations in many papers by his employers CNRS and ETH Zürich (see my various reports here). The Voinnet lab in Strasbourg had since been led by his right-hand man, Patrice Dunoyer, first author on 3 retracted papers, who also admitted his own data manipulations in several more instances (most recent Voinnet/Dunoyer retraction and correction list here). A serious institute might have reconsidered collaborating with such a questionable scientist as Dunoyer, not so CNRS and its IBMP (which is actually just as fair, because also the Swiss ETH kept his boss Voinnet as their professor). Dunoyer was only punished by a one-month suspension back then in 2015, to CNRS leadership he seems to be a perfect scientist to lead a research lab in this plant science institute. Indeed, Dunoyer is apparently well integrated at IBMP: on March 8th the review board will not only be judging his scientific performance, but also that of his several IBMP colleagues whose publications were also flagged for data integrity concerns on PubPeer, e.g. Christophe Ritzenthaler, Véronique Ziegler-Graff and Pascal Genschik. Incidentally, IBMP invited as review committee members such international scientists who will be well able to understand this delicate matter, because, like for example Martin Crespi, director of the Institute of Plant Sciences in Paris-Saclay, or Serge Delrot, professor at University of Bordeaux, their own publications were reported on PubPeer for serious data integrity concerns as well. One could quip here: it takes one to know one. Continue reading “The travelling circus of research integrity in Strasbourg”
The academic career of the Irish microbiologist Robert Ryan is apparently over. Following an internal misconduct investigation at the University of Dundee, Ryan had to resign from his position as group leader and lost the prestigious funding from the Wellcome Trust. Prior to this, he was suspended by his employer, while the European molecular biology society EMBO terminated his participation in the EMBO Young Investigator programme. Peculiarly, there never were any press releases or official communications. The University of Dundee apparently chose instead to leak internal emails to media (for details see my reporting here and here), the most recent announcement about Ryan’s “resignation” was no exception.
Ryan’s however is not the only name crowning all those papers now under suspicion of misconduct. Another recurrent name belongs to his former mentor of many years, the leading plant pathogen researcher Maxwell Dow, from the University College Cork (UCC) in Ireland. The PubPeer evidence is quite heavy against Ryan and Dow papers, and in fact UCC once suggested to me that they would initiate an investigation. Other media never even mentioned Dow’s name. Only on my site was his most obvious responsibility for Ryan’s research discussed, nowhere else. Now Dow decided to act against this unwelcome reporting. He submitted a DMCA takedown request to my website host WordPress and LinkedIn’s Slideshare, targeting my article and my teaching presentation from a research integrity workshop in Catania, Italy. Dow’s copyright claim concerned a photograph of his together with Ryan which was made publicly available by their university in this UCC press release. Continue reading “Ryan’s mentor Dow pretends copyright to combat my reporting”
Protein expression analysis by western blots appears to be the weak spot of life science, because these blots are so often reported to be manipulated. However, this is only because anybody, even without any background in biology can spot re-used western blot bands, just using a good eye or some computer skills. Unlike with other analytical tools, like real-time PCR or microscopy imaging, you don’t need specialist knowledge or access to raw data to spot digital manipulations of western blots. One of the most famous western blot breeders is the Brazilian diabetes researcher Mario Saad (see whistleblower reports on my site here and here). Below is the case of his two colleagues from Poland.
Some time ago, I was contacted by a Polish scientist with a dossier of suspected western blot duplications in the publication of the pharmacologist Bożena Gabryel from the Department of Pharmacology at the Medical University of Silesia in Katowice, Poland. Gabryel specializes in oxidative stress research, four of her publications on this topic were accused to feature duplicated western blots, in different context. Sometimes suspicions were raised that selected individual bands in different western blots look too similar, which might suggest manipulative band duplications.
Soon after, another whistleblower independently contacted me with another dossier about yet another set of Gabryel’s papers, all featuring as lead or even corresponding author Krzysztof Łabuzek, who is an adjunct professor at this same Medical University of Silesia with interest in immune system and who also has a clinical practice for internal medicine in a small town near Katowice. Labuzek’s papers seem to feature a whole gallery of re-used western blots, as the dossier suggests. Additionally, that second whistleblower expressed concerns about western blot splicing and suspected band re-used in papers featuring the first author Joanna Ślusarczyk, PhD student in the lab of Agnieszka Basta-Kaim at the Polish Academy of Sciences in Krakow. Basta-Kaim is also co-author on one Gabryel paper now suspected of data manipulations.
Below I am publishing the most recent dossier authored by the four whistle-blowers from the Karolinska Institutet (KI) in Sweden: Oscar Simonson, Karl-Henrik Grinnemo, Matthias Corbascio and Thomas Fux. Two of their earlier notifications of research misconduct to KI by their former colleague Paolo Macchiarini are available in full on my site, here and here.
This time it is about Macchiarini’s trachea transplants in Russia, and the so-called Megagrant funding he received from the Russian government for his work at the Kuban State Medical University in Krasnodar. The accusation goes that the KI star surgeon misrepresented the true outcomes of his two first disastrous human experiments with a plastic trachea, performed at KI on the patients Andemariam Beyene and Chris Lyles, both of who died. Also, the whistle-blowers criticise that KI failed to investigate these failed transplants and patient deaths and did not report those to the Russian authorities, which might have helped avoid the unnecessary deaths of at least two Russian patients, Yulia Tuulik and Alexander Zozulya. Continue reading “Macchiarini and his Russian megagrant”
The German central research funding society DFG has issued a press release about two decisions on research misconduct. The main point concerns the Bremen University diabetes researcher Kathrin Maedler (see my story here) and strips her of the prestigious Heisenberg professorship awarded to her by DFG in 2014, after having found her guilty of misconduct and co-responsible for misrepresentation of research data in 6 publications. Today’s DFG decision stands in contrast to two previous investigations by the Universities of Bremen and Zürich, which acquitted Maedler of all suspicions of misconduct and upheld the validity of all her published research results. This is my Google-translate assisted English translation of the Mädler section of DFG press release.
Scientific misconduct: Decision in two DFG procedures
The General Committee decides to withdraw Heisenberg’s professorship […]
The German Research Foundation (DFG) is once again drawing conclusions from the scientific misconduct by the scientists it funded. In its meeting on 8 December 2016 in Bonn, the main committee of the largest research funding organization and central self-administration organization for science in Germany decided in two cases to implement measures in accordance with the DFG procedural rules for dealing with scientific misconduct. In doing so, it followed the recommendation of the DFG committee to investigate allegations of scientific misconduct. Continue reading “Kathrin Maedler loses Heisenberg Professorship, found guilty of misconduct by DFG”
The prize-winning German pharmacologist and diabetes researcher Kathrin Maedler is regularly in the German and international news, either as a celebrated genius about to cure diabetes or as a potential cheater, responsible for masses of duplicated images in her publications. The rectorate of her own University of Bremen absolved their professor of all suspicions of data manipulations, while admitting image duplications and loss of original data. One argument was that all results were successfully reproduced, yet by whom: that the Bremen rectorate prefers not to answer, together with all other relevant questions which would have made this investigation anywhere credible. In the same vein, another investigation at the University of Zürich in Switzerland, where Maedler did her PhD in 2000-2004 under the supervision of Marc Donath, absolved them both of any suspicion of misconduct as well, while refusing to provide any further explanations. Meanwhile, other labs have refuted Maedler’s discoveries, but these publications were dismissed by the University of Bremen as irrelevant. Maedler also had to retract a publication Ardestani et al 2011 from the Journal of Biological Chemistry (which is known to have a rather tough stance on suspected misconduct). Continue reading “Kathrin Maedler: persecuted genius or zombie scientist?”
Great scientists never have any conflicts of interests, and in the case of the investigation of the research misconduct by the plant scientist Olivier Voinnet, led by his Swiss employer ETH Zürich, this was also apparently the case. Voinnet was found guilty of misconduct and admitted image manipulations in many papers. Yet his science remained largely unquestioned, and even original data behind the most outrageously manipulated figures was said to have been available in many cases. The ETH investigation recommended 6 retractions, one of which was even avoided thanks to the concerns the journal Science had towards that paper’s junior authors (Voinnet’s current retraction count stands at 8 papers and almost 20 corrections, where manipulated data was simply exchanged with new one). Professor emeritus Witold Filipowicz, of the Friedrich-Mieschner-Institute in Basel, is like Voinnet a specialist in the field of regulatory small RNAs, and he was therefore one of two external Voinnet investigators whom ETH invited in early 2015. It did not matter to ETH that it was actually Filipowicz who nominated Voinnet for the EMBO Gold Medal, which the disgraced plant scientist then lost after EMBO’s own investigation into his many years of data manipulation. Continue reading “The Voinnet investigator and the tricky issue of conflict of interests”